WO2008008024A2 - Formes polymorphes de chlorhydrate de spirapril - Google Patents

Formes polymorphes de chlorhydrate de spirapril Download PDF

Info

Publication number
WO2008008024A2
WO2008008024A2 PCT/GB2007/002653 GB2007002653W WO2008008024A2 WO 2008008024 A2 WO2008008024 A2 WO 2008008024A2 GB 2007002653 W GB2007002653 W GB 2007002653W WO 2008008024 A2 WO2008008024 A2 WO 2008008024A2
Authority
WO
WIPO (PCT)
Prior art keywords
ray powder
powder diffractogram
spirapril hydrochloride
polymorph
spirapril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2007/002653
Other languages
English (en)
Other versions
WO2008008024A9 (fr
WO2008008024A3 (fr
Inventor
Aleksandar Danilovski
Maja Devcic
Marina Marinkovic
Ernest Mestrovic
Tina Mundofer
Petar Tudja
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Original Assignee
Pliva Hrvatska doo
Pliva Istrazivanje i Razvoj doo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Hrvatska doo, Pliva Istrazivanje i Razvoj doo filed Critical Pliva Hrvatska doo
Priority to EP07848377A priority Critical patent/EP2069360A2/fr
Publication of WO2008008024A2 publication Critical patent/WO2008008024A2/fr
Publication of WO2008008024A9 publication Critical patent/WO2008008024A9/fr
Publication of WO2008008024A3 publication Critical patent/WO2008008024A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne de nouvelle formes polymorphes d'hydrochlorure de spirapril, des procédés de préparation des nouvelles formes polymorphes, des compositions pharmaceutiques les contenant, leurs utilisations thérapeutiques et des procédés de traitement les employant procédés.
PCT/GB2007/002653 2006-07-13 2007-07-13 Formes polymorphes de chlorhydrate de spirapril Ceased WO2008008024A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP07848377A EP2069360A2 (fr) 2006-07-13 2007-07-13 Formes polymorphes de chlorhydrate de spirapril

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0613927.3 2006-07-13
GBGB0613927.3A GB0613927D0 (en) 2006-07-13 2006-07-13 Pharmaceutically acceptable salt and polymorphic forms

Publications (3)

Publication Number Publication Date
WO2008008024A2 true WO2008008024A2 (fr) 2008-01-17
WO2008008024A9 WO2008008024A9 (fr) 2008-03-13
WO2008008024A3 WO2008008024A3 (fr) 2009-02-12

Family

ID=36955585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/002653 Ceased WO2008008024A2 (fr) 2006-07-13 2007-07-13 Formes polymorphes de chlorhydrate de spirapril

Country Status (4)

Country Link
EP (1) EP2069360A2 (fr)
DE (2) DE202007019054U1 (fr)
GB (1) GB0613927D0 (fr)
WO (1) WO2008008024A2 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4470972A (en) 1981-04-28 1984-09-11 Schering Corporation 7-Carboxyalkylaminoacyl-1,4-dithia-7-azaspiro[4.4]-nonane-8-carboxylic acids
US4847384A (en) * 1987-03-12 1989-07-11 Sandoz Pharm. Corp. Process for the preparation of certain nitrogen-containing mono- and bicyclic ace inhibitors, and novel intermediates useful therefor
US5403593A (en) 1991-03-04 1995-04-04 Sandoz Ltd. Melt granulated compositions for preparing sustained release dosage forms

Also Published As

Publication number Publication date
DE102007032613A1 (de) 2008-01-24
EP2069360A2 (fr) 2009-06-17
GB0613927D0 (en) 2006-08-23
WO2008008024A9 (fr) 2008-03-13
DE202007019054U1 (de) 2010-05-12
WO2008008024A3 (fr) 2009-02-12

Similar Documents

Publication Publication Date Title
ES2246396T3 (es) Sales de tartrato de 5,8,14-triazatetraciclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaeno.
JP2019515024A (ja) ボルチオキセチンのパモ酸塩及びその結晶形
US6355269B1 (en) Oral compositions of levosimendan
EP1461040B1 (fr) Sels succiniques de 5,8,14-triazatetracyclo 10.3.1.02,11.0 4,9 -hexadeca-2(11),3,5,7,9-pentaene et compositions pharmaceutiques associees
WO2003093253A1 (fr) Sulfamides spirocycliques substitues par alkynyle, destines au traitement de la maladie d'alzheimer
US20260022115A1 (en) Polymorphic forms of a substituted-quinoxaline-type bridged-piperdine compound
EA005529B1 (ru) Цитрат 5,8,14-триазатетрацикло-(10.3.1.0.0)-гексадека-2(11),3,5,7,9-пентаена
US20120142743A1 (en) Pharmaceutically acceptable salt and polymorphic forms of flupirtine maleate
KR20150046369A (ko) 데페라시록스 (ｉｃｌ６７０ａ)의 다형체 형태
JP6748123B2 (ja) サクビトリルカルシウム塩
EP3468968B1 (fr) Formes solides de ceftolozane et procédés de préparation
CA3188250A1 (fr) Formes cristallines d'un inhibiteur d'o-glycoproteine-2-acetamido-2-desoxy-3-d-glucopyranosidase
WO2008008024A2 (fr) Formes polymorphes de chlorhydrate de spirapril
EP2057170A2 (fr) Formes polymorphes de chlorhydrate de spirapril
RU2177478C2 (ru) Безводная кристаллическая форма гидрохлорида r(-)-n-(4,4-ди (3-метилтиен -2-ил) бут-3-енил)-нипекотиновой кислоты, способ ее получения, фармацевтическая композиция и способ лечения
SK281980B6 (sk) Kryštallický (+)l-hydrogenvínan, spôsob jeho prípravy, farmaceutický prostriedok s jeho obsahom a jeho použitie
WO2008040935A1 (fr) Nouvelles formes polymorphes de la prégabaline
CN110740988A (zh) 制备l-鸟氨酸苯乙酸盐的方法
CA2439117C (fr) Formes polymorphes de n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide
CA2230303C (fr) Polymorphes du promedicament 6-n-(l-ala-l-ala)-trovafloxacine
CA3127469C (fr) Formes polymorphes d'un compose de piperidine ponte de type quinoxaline substituee
RU2838463C2 (ru) Акрилсодержащие модуляторы ядерного транспорта и их применение
EP1880997A1 (fr) Cristal de compose 1-methylcarbapenem
WO2006090263A1 (fr) Chlorhydrate de donepezil de formule i stable et son procede de preparation et d'utilisation dans des compositions pharmaceutiques
KR20240116208A (ko) 결정형의 미라베그론 신규염, 이의 제조방법 및 이를 포함하는 약학적 조성물

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2007848377

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: RU

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07769012

Country of ref document: EP

Kind code of ref document: A2

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07848377

Country of ref document: EP

Kind code of ref document: A2